Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects

Atherosclerosis. 1999 Oct;146(2):381-90. doi: 10.1016/s0021-9150(99)00153-7.

Abstract

Heparin given intravenously enhances lipolysis, although fasting lipids are not markedly altered in long-term administration. In the present study we investigated heparin-induced acute perturbation of VLDL subclass metabolism. Eight men were examined during a control study and during an 8.5 h infusion of heparin. 2H3-leucine was used as tracer and kinetic constants derived using a non-steady-state model. Heparin infusion increased both plasma lipoprotein and hepatic lipase activity and raised plasma FFAs two-fold (P < 0.001). The fractional catabolic rate (FCR) of VLDL1 apo B increased on heparin (25.7 +/- 4.2 and 10.8 +/- 1.7 pools/d, heparin vs. control, P < 0.02). The FCR of VLDL2 apo B increased to 12.6 +/- 1.9 pools/d on heparin vs. 8.8 +/- 1.1 pools/d during the control (NS). Total VLDL apo B production was not significantly changed (824 +/- 45 and 692 +/- 91 mg/d, heparin vs. control, NS). We conclude that during heparin infusion, the catabolism of especially large triglyceride-rich VLDL1 apo B is greatly increased. However, although the FFA levels were high during the heparin study, the production of total VLDL apo B did not rise. These findings are consistent with the known action of heparin on lipoprotein lipase but indicate that acute increase in plasma FFA levels does not lead to a rise in VLDL apo B production.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anticoagulants / pharmacology*
  • Apolipoproteins B / metabolism*
  • Blood Glucose / metabolism
  • Cholesterol, VLDL / metabolism*
  • Fatty Acids, Nonesterified / blood
  • Gas Chromatography-Mass Spectrometry
  • Heparin / pharmacology*
  • Humans
  • Insulin / blood
  • Lipase / metabolism
  • Lipolysis / drug effects*
  • Lipoprotein Lipase / blood
  • Liver / enzymology
  • Male
  • Middle Aged
  • Reference Values

Substances

  • Anticoagulants
  • Apolipoproteins B
  • Blood Glucose
  • Cholesterol, VLDL
  • Fatty Acids, Nonesterified
  • Insulin
  • Heparin
  • Lipase
  • Lipoprotein Lipase